Surgical Tactics Optimization for Treatment of BRAF Positive Papillary Thyroid Cancer

Clinical and experimental thyroidology
doi 10.14341/ket9424
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Endocrinology Research Centre

Related search

Prognostic Utility of BRAF Mutation in Papillary Thyroid Cancer

Molecular and Cellular Endocrinology
BiochemistryEndocrinologyMolecular Biology
2010English

The Role of Braf Mutation Status in Surgical Treatment of Well-Differentiated Thyroid Cancer

Opuholi Golovy i Sei
OncologyRadiologyPharmacologyCancer ResearchNuclear MedicineOtorhinolaryngologyImagingSurgery
2016English

Vemurafenib for BRAFV600E-positive Metastatic Papillary Thyroid Cancer – Authors' Response

The Lancet Oncology
Oncology
2016English

Redifferentiation of Iodine-Refractory BRAF V600e-Mutant Metastatic Papillary Thyroid Cancer With Dabrafenib

Clinical Cancer Research
Cancer ResearchOncology
2014English

Tumorigenesis of Papillary Thyroid Cancer Is Not BRAF-Dependent in Patients With Acromegaly

PLoS ONE
Multidisciplinary
2014English

Radiomics Study of Thyroid Ultrasound for Predicting BRAF Mutation in Papillary Thyroid Carcinoma: Preliminary Results

American Journal of Neuroradiology
MedicineNuclear MedicineNeurologyImagingRadiology
2020English

Optimization of Surgical Treatment Tactics for Patients With Hip-Spine Syndrome: A Clinical Case

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2019English

Total Thyroidectomy for Papillary Thyroid Cancer

VideoEndocrinology
2019English

Targeted Treatment of Papillary Craniopharyngiomas Harboring BRAF V600E Mutations

Cancer
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy